- Home
- TSAT vs JUNS Comparison
TSAT vs JUNS Comparison
Compare TSAT & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- JUNS
- Stock Information
- Founded
- TSAT 1969
- JUNS 2015
- Country
- TSAT Canada
- JUNS United States
- Employees
- TSAT N/A
- JUNS N/A
- Industry
- TSAT Metal Fabrications
- JUNS
- Sector
- TSAT Industrials
- JUNS
- Exchange
- TSAT Nasdaq
- JUNS NYSE
- Market Cap
- TSAT 236.1M
- JUNS 281.4M
- IPO Year
- TSAT 1996
- JUNS 2024
- Fundamental
- Price
- TSAT $17.45
- JUNS $5.42
- Analyst Decision
- TSAT Hold
- JUNS
- Analyst Count
- TSAT 1
- JUNS 0
- Target Price
- TSAT $9.00
- JUNS N/A
- AVG Volume (30 Days)
- TSAT 52.0K
- JUNS 494.3K
- Earning Date
- TSAT 11-14-2024
- JUNS 02-11-2025
- Dividend Yield
- TSAT N/A
- JUNS N/A
- EPS Growth
- TSAT N/A
- JUNS N/A
- EPS
- TSAT 2.55
- JUNS N/A
- Revenue
- TSAT $450,756,875.00
- JUNS N/A
- Revenue This Year
- TSAT N/A
- JUNS N/A
- Revenue Next Year
- TSAT N/A
- JUNS N/A
- P/E Ratio
- TSAT $6.08
- JUNS N/A
- Revenue Growth
- TSAT N/A
- JUNS N/A
- 52 Week Low
- TSAT $6.93
- JUNS $3.86
- 52 Week High
- TSAT $19.37
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- TSAT 57.48
- JUNS N/A
- Support Level
- TSAT $14.31
- JUNS N/A
- Resistance Level
- TSAT $19.37
- JUNS N/A
- Average True Range (ATR)
- TSAT 1.18
- JUNS 0.00
- MACD
- TSAT -0.17
- JUNS 0.00
- Stochastic Oscillator
- TSAT 62.06
- JUNS 0.00
About TSAT Telesat Corporation and Class B Variable Voting Shares
Telesat Corp is a global satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.